• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD248诱导癌症相关成纤维细胞上的PD-L1表达以促进非小细胞肺癌免疫逃逸。

CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape.

作者信息

Yang Zeyang, Wang Xuanyin, Zhu Xu, Li Long, Zeng Xianling, Ren Jiaming, Wang Lu, Wu Jiangwei, Zhang Qiaoling, Wang Siyu, Lu Maoqin, Zhai Juan, Liu Xinlei, Xiao Jing, Jin Tao, Zhang Ying, Wang Yun, Zhang Jian, Zeng Zhu, Wu Jieheng

机构信息

Department of Immunology, Guizhou Medical University, Guiyang, China.

Department of Thoracic Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.

出版信息

Front Cell Dev Biol. 2025 Jul 15;13:1635915. doi: 10.3389/fcell.2025.1635915. eCollection 2025.

DOI:10.3389/fcell.2025.1635915
PMID:40735646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12304000/
Abstract

BACKGROUND

Tumor immune escape is a critical step in tumor progression. Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) express abundant PD-L1 and suppress the functions of CD8T cells, enablingd immune escape. CD248 is a candidate bioindicator for CAFs associated with non-small cell lung cancer (NSCLC), although its involvement in immune escape is not known.

METHODS

Fibroblasts were isolated from tumor and normal lung tissues from patients. We detected the expression of CD248 and PD-L1 on CAFs. Then, the influence of CAFs inhibited the function of CD8T cells promoting NSCLC immune escape was assessed and . Finally, explored the mechanisms of which CD248 induced PD-L1 expression on CAFs.

RESULTS

Herein, we demonstrated that CD248 increased CAF PD-L1 levels, inhibiting CD8T-cell function, thereby promoting NSCLC cell invasion and migration. CD248-induced FAK/Src/JNK/c-Jun axis activation promoted PD-L1 expression on CAFs. In tumor-bearing mice, lung tumors grew significantly slower, and the amount of granzyme BCD8T cells was greater in fibroblast-specific CD248 gene knockout mice than in wild-type mice. More importantly, we found that tislelizumab efficiency was improved in CD248 gene knockout mice.

CONCLUSION

Our findings demonstrate that CD248 activates FAK/Src/JNK/c-Jun, thereby inducing PD-L1 expression on CAFs, which promotes NSCLC immune escape.

摘要

背景

肿瘤免疫逃逸是肿瘤进展的关键步骤。肿瘤微环境(TME)中的癌症相关成纤维细胞(CAF)表达大量程序性死亡配体1(PD-L1)并抑制CD8 + T细胞功能,从而导致免疫逃逸。CD248是与非小细胞肺癌(NSCLC)相关的CAF的候选生物标志物,但其在免疫逃逸中的作用尚不清楚。

方法

从患者的肿瘤和正常肺组织中分离成纤维细胞。我们检测了CAF上CD248和PD-L1的表达。然后,评估CAF对促进NSCLC免疫逃逸的CD8 + T细胞功能的抑制作用。最后,探讨CD248诱导CAF上PD-L1表达的机制。

结果

在此,我们证明CD248增加了CAF的PD-L1水平,抑制了CD8 + T细胞功能,从而促进了NSCLC细胞的侵袭和迁移。CD248诱导的黏着斑激酶(FAK)/Src/应激活化蛋白激酶(JNK)/c-Jun轴激活促进了CAF上PD-L1的表达。在荷瘤小鼠中,成纤维细胞特异性CD248基因敲除小鼠的肺肿瘤生长明显较慢,颗粒酶B + CD8 + T细胞数量比野生型小鼠更多。更重要的是,我们发现替雷利珠单抗在CD248基因敲除小鼠中的疗效得到了改善。

结论

我们的研究结果表明,CD248激活FAK/Src/JNK/c-Jun,从而诱导CAF上PD-L1的表达,促进NSCLC免疫逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/babe9c050149/fcell-13-1635915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/84525ff4b943/fcell-13-1635915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/967c48c702f2/fcell-13-1635915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/34cca1485eae/fcell-13-1635915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/7809cc94e544/fcell-13-1635915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/31c614dc85c8/fcell-13-1635915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/816867f0e991/fcell-13-1635915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/babe9c050149/fcell-13-1635915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/84525ff4b943/fcell-13-1635915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/967c48c702f2/fcell-13-1635915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/34cca1485eae/fcell-13-1635915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/7809cc94e544/fcell-13-1635915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/31c614dc85c8/fcell-13-1635915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/816867f0e991/fcell-13-1635915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e76/12304000/babe9c050149/fcell-13-1635915-g007.jpg

相似文献

1
CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape.CD248诱导癌症相关成纤维细胞上的PD-L1表达以促进非小细胞肺癌免疫逃逸。
Front Cell Dev Biol. 2025 Jul 15;13:1635915. doi: 10.3389/fcell.2025.1635915. eCollection 2025.
2
CD248-expressing cancer-associated fibroblasts induce epithelial-mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages.表达 CD248 的癌相关成纤维细胞通过诱导 M2 极化的巨噬细胞诱导非小细胞肺癌的上皮-间充质转化。
Sci Rep. 2024 Jun 21;14(1):14343. doi: 10.1038/s41598-024-65435-0.
3
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibody.小麦黄素通过抑制血小板衍生生长因子-BB(PDGF-BB)诱导的SRC/丝裂原活化蛋白激酶(MAPK)/活化蛋白-1(AP-1)/程序性死亡配体1(PD-L1)信号通路,选择性对抗KRAS突变的非小细胞肺癌,并增强抗程序性死亡蛋白1(PD-1)抗体的抗肿瘤作用。
Front Pharmacol. 2025 Jun 17;16:1594213. doi: 10.3389/fphar.2025.1594213. eCollection 2025.
4
Aurantio-obtusin modulates Wilms Tumour 1 within the breast tumour microenvironment reducing immunosuppression and tumour growth.橙钝叶决明素在乳腺肿瘤微环境中调节威尔姆斯瘤蛋白1,减少免疫抑制和肿瘤生长。
Cell Commun Signal. 2025 Jul 1;23(1):309. doi: 10.1186/s12964-025-02292-y.
5
Lung cancer-associated fibroblasts-mediated collagen deposition drives mediastinal lymph node metastasis in non-small cell lung cancer.肺癌相关成纤维细胞介导的胶原沉积驱动非小细胞肺癌纵隔淋巴结转移。
Front Oncol. 2025 Jun 12;15:1597585. doi: 10.3389/fonc.2025.1597585. eCollection 2025.
6
Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment.负载GLUT1抑制剂的癌症相关成纤维细胞衍生的细胞外囊泡与抗PD-L1协同作用,通过降解基质硬度和重塑肿瘤微环境来抑制肿瘤生长。
J Control Release. 2025 Jul 1:113998. doi: 10.1016/j.jconrel.2025.113998.
7
Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapy.舒林酸调节三阴性乳腺癌对抗程序性死亡受体配体1(anti-PD-L1)免疫疗法的反应。
bioRxiv. 2025 Jun 17:2025.06.11.659159. doi: 10.1101/2025.06.11.659159.
8
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis.比较 PD-1/PD-L1 联合疗法在晚期 NSCLC 一线治疗中的疗效和安全性:一项更新的系统评价和网络荟萃分析。
Clin Transl Oncol. 2024 Oct;26(10):2488-2502. doi: 10.1007/s12094-024-03442-3. Epub 2024 Apr 16.
9
INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling.抑制素βA通过抑制γ干扰素信号通路促进肿瘤生长并诱导对程序性死亡受体配体1阻断的抗性。
Acta Pharmacol Sin. 2025 Feb;46(2):448-461. doi: 10.1038/s41401-024-01381-x. Epub 2024 Sep 2.
10
M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.M6A 调节因子表达模式预测非小细胞肺癌的免疫微环境和预后。
J Cancer Res Clin Oncol. 2022 Oct;148(10):2803-2814. doi: 10.1007/s00432-022-04032-y. Epub 2022 May 20.

本文引用的文献

1
Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives.小细胞肺癌的分子亚型与靶向治疗策略:进展、挑战及未来展望
Molecules. 2025 Apr 12;30(8):1731. doi: 10.3390/molecules30081731.
2
Oligometastatic NSCLC: Current Perspectives and Future Challenges.寡转移非小细胞肺癌:当前观点与未来挑战
Curr Oncol. 2025 Jan 29;32(2):75. doi: 10.3390/curroncol32020075.
3
Emerging Targets in Non-Small Cell Lung Cancer.非小细胞肺癌的新兴靶点。
Int J Mol Sci. 2024 Sep 18;25(18):10046. doi: 10.3390/ijms251810046.
4
Non-small-cell lung cancer.非小细胞肺癌。
Nat Rev Dis Primers. 2024 Sep 26;10(1):71. doi: 10.1038/s41572-024-00551-9.
5
CD248-expressing cancer-associated fibroblasts induce epithelial-mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages.表达 CD248 的癌相关成纤维细胞通过诱导 M2 极化的巨噬细胞诱导非小细胞肺癌的上皮-间充质转化。
Sci Rep. 2024 Jun 21;14(1):14343. doi: 10.1038/s41598-024-65435-0.
6
Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.细胞凋亡,肿瘤与 T 细胞之间的代谢“正面交锋”:对免疫治疗的影响。
Cells. 2024 May 27;13(11):924. doi: 10.3390/cells13110924.
7
IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer.CD248 表达的肿瘤相关成纤维细胞来源的 IL-8 导致非小细胞肺癌对顺铂耐药。
J Cell Mol Med. 2024 Feb;28(4):e18185. doi: 10.1111/jcmm.18185.
8
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
9
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity.氨基酸代谢重编程:为 T 细胞抗肿瘤免疫带来新的曙光。
J Exp Clin Cancer Res. 2023 Nov 3;42(1):291. doi: 10.1186/s13046-023-02845-4.
10
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.定义肿瘤微环境中的癌症相关成纤维细胞(CAFs):癌症免疫治疗的新机遇和临床试验的进展。
Mol Cancer. 2023 Oct 2;22(1):159. doi: 10.1186/s12943-023-01860-5.